These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11295882)

  • 1. Variability of blood-brain ratios of phenylalanine in typical patients with phenylketonuria.
    Rupp A; Kreis R; Zschocke J; Slotboom J; Boesch C; Rating D; Pietz J
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):276-84. PubMed ID: 11295882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria.
    Möller HE; Weglage J; Bick U; Wiedermann D; Feldmann R; Ullrich K
    Pediatrics; 2003 Dec; 112(6 Pt 2):1580-3. PubMed ID: 14654669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.
    Möller HE; Weglage J; Wiedermann D; Ullrich K
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1184-91. PubMed ID: 9809507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vivo NMR spectroscopy in patients with phenylketonuria: changes of cerebral phenylalanine levels under dietary treatment.
    Möller HE; Vermathen P; Ullrich K; Weglage J; Koch HG; Peters PE
    Neuropediatrics; 1995 Aug; 26(4):199-202. PubMed ID: 8544958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of brain concentrations of phenylalanine and its clinical significance in patients with phenylketonuria determined by in vivo 1H magnetic resonance spectroscopy.
    Pietz J; Kreis R; Boesch C; Penzien J; Rating D; Herschkowitz N
    Pediatr Res; 1995 Nov; 38(5):657-63. PubMed ID: 8552430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-individual variation in brain phenylalanine concentration in patients with PKU is not caused by genetic variation in the 4F2hc/LAT1 complex.
    Møller LB; Paulsen M; Koch R; Moats R; Guldberg P; Güttler F
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S119-23. PubMed ID: 16176881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia.
    Weglage J; Pietsch M; Feldmann R; Koch HG; Zschocke J; Hoffmann G; Muntau-Heger A; Denecke J; Guldberg P; Güttler F; Möller H; Wendel U; Ullrich K; Harms E
    Pediatr Res; 2001 Apr; 49(4):532-6. PubMed ID: 11264437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of brain phenylalanine concentration assessed by in vivo proton magnetic resonance spectroscopy in phenylketonuria.
    Leuzzi V; Bianchi MC; Tosetti M; Carducci CL; Carducci CA; Antonozzi I
    J Inherit Metab Dis; 2000 Sep; 23(6):563-70. PubMed ID: 11032331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults.
    Moats RA; Moseley KD; Koch R; Nelson M
    Pediatrics; 2003 Dec; 112(6 Pt 2):1575-9. PubMed ID: 14654668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain white matter lesions of children with phenylketonuria before and after treatment].
    Wang ZX; Zhou ZS; Yu WM
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of computerized neuropsychological tests and of nuclear magnetic resonance spectroscopy in clinical assessment of adult patients with phenylketonuria].
    Bik-Multanowski M; Pietrzyk JJ
    Przegl Lek; 2011; 68(3):127-31. PubMed ID: 21812225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0 tesla MRI and magnetic resonance spectroscopy (1H MRS) study.
    Leuzzi V; Tosetti M; Montanaro D; Carducci C; Artiola C; Carducci C; Antonozzi I; Burroni M; Carnevale F; Chiarotti F; Popolizio T; Giannatempo GM; D'Alesio V; Scarabino T
    J Inherit Metab Dis; 2007 Apr; 30(2):209-16. PubMed ID: 17245558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.
    van Spronsen FJ; Reijngoud DJ; Smit GP; Nagel GT; Stellaard F; Berger R; Heymans HS
    J Clin Invest; 1998 Jun; 101(12):2875-80. PubMed ID: 9637722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global and regional volume changes in the brains of patients with phenylketonuria.
    Pérez-Dueñas B; Pujol J; Soriano-Mas C; Ortiz H; Artuch R; Vilaseca MA; Campistol J
    Neurology; 2006 Apr; 66(7):1074-8. PubMed ID: 16606920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy.
    Pietz J; Rupp A; Ebinger F; Rating D; Mayatepek E; Boesch C; Kreis R
    Pediatr Res; 2003 Apr; 53(4):654-62. PubMed ID: 12612190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of neonatal protein metabolism and nutrition on screening for phenylketonuria.
    Ponzone A; Spada M; Roasio L; Porta F; Mussa A; Ferraris S
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):561-9. PubMed ID: 18493213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.